| (V1081) |
Synergisms of stem cell mobilization and DPP-IV/CD26 inhibition augment myocardial regeneration in mice with targeted cell cycle activation in adult cardiomyocytes |
|
M.-M. Zaruba, W. Zhu, M. Soonpaa, S. Reuter, W.-M. Franz, L. Field (München; Indianapolis, US) |
| (V1082) |
Heparin disrupts the CXCR4 / SDF-1 Axis and impairs the Functional Capacity of Bone Marrow-derived Mononuclear Cells (BMC) used for Cardiovascular Cell Therapy |
|
F. Seeger, T. Rasper, D. Leistner, E. Hergenreider, K. Sommer, J.-H. Rohde, E. Chavakis, R. Henschler, B. Aßmus, A. M. Zeiher, S. Dimmeler (Frankfurt am Main) |
| (V1083) |
Parvovirus B19 (B19V) infection induces apoptosis of circulating angiogenic cells via a caspase-8/-10 dependent mechanism leading to reduced endothelial regeneration |
|
T. Zobel, N. Morozkina, T. Gossler, M. Becher, S. Schrepfer, C. Tschöpe, H.-D. Volk, H.-P. Schultheiss, C. Schmidt-Lucke (Berlin, Hamburg) |
| (V1084) |
The role of the integrin activator kindlin3 in the homing process of haematopoetic stem- and progenitor cells (HSPC) into the murine bone marrow |
|
M. Orban, R. Ruppert, S. Longhi, J. Schneider, A. Suhr, A. Tirniceriu, M. Moser, R. Fässler, S. Massberg (München) |
| (V1085) |
Specifically Designed, Bioactive Nanofiber-Matrix Supports Cell-based Therapy in Ischemic Tissue Repair |
|
J. Tongers, M. J. Webber, M.-A. Renault, J. G. Roncalli, K.-T. Marquardt, A. Menon, E. Klaychko, T. Thorne, J. Bauersachs, S. I. Stupp, D. W. Losordo (Hannover; Chicago, US) |
| (V1086) |
Bifunctional proteins as a therapeutic strategy for improved myocardial repair in cardiovascular diseases |
|
M. Ziegler, T. Schönberger, Y. Baumer, C. Ochmann, T. Jürgens, M. Elvers, C. Leder, B. Schlosshauer, M. Gawaz (Tübingen, Reutlingen) |